177Lu-labeled cyclic polyaminophosphonates as potential agents for bone pain palliation.
about
Coordination ability of trans-cyclohexane-1,2-diamine-N,N,N',N'-tetrakis(methylenephosphonic acid) towards lanthanide(III) ions.Metal complexes of cyclen and cyclam derivatives useful for medical applications: a discussion based on thermodynamic stability constants and structural data.The effect of the amide substituent on the biodistribution and tolerance of lanthanide(III) DOTA-tetraamide derivatives.Bisphosphonates as radionuclide carriers for imaging or systemic therapy.Radiopharmaceuticals for metastatic bone pain palliation: available options in the clinical domain and their comparisons.Production, quality control, and determination of human absorbed dose of no carrier added 177 Lu-risedronate for bone pain palliation therapy.Production, biodistribution assessment and dosimetric evaluation of (177)Lu-TTHMP as an agent for bone pain palliation.Production, quality control, and bio-distribution studies of (159)Gd-EDTMP as a palliative agent for bone painFeasibility study for production and quality control of Yb-175 as a byproduct of no carrier added Lu-177 preparation for radiolabeling of DOTMP.Production and quality control 177Lu (NCA)-DOTMP as a potential agent for bone pain palliation.MEDICINAL RADIOPHARMACEUTICAL CHEMISTRY OF METAL RADIOPHARMACEUTICALSRadiochemical and biological behaviour of 153Sm and 166Ho complexes anchored by a novel bis(methylphosphonate) tetraazamacrocycle
P2860
Q31060438-04B3C725-2279-410F-9B0D-DB6DC2D53F1EQ31116849-0CCE005E-C3C5-4F61-B79D-47BA11890A7CQ37228737-F3F5CFF8-EAF9-4E60-8BD7-9ACFB0CE5F5BQ37924117-43D27EC3-96DC-4144-8149-A05D021DF4A3Q39042390-EBAF2C0A-0490-4374-90FA-9638D807EAEFQ39175247-3E8DC56B-8CB3-48D7-B66D-FA01A33D7F58Q39607619-0C5FC61C-B509-43D7-A631-3F48C38A110AQ41852414-7455455D-D6D4-4E7F-958B-C1741DCEE2B1Q47232721-6375D968-8B57-4CE3-9C7F-C86030C39B49Q52784096-4A4BBA0B-DEE4-4BFE-97AF-936DAA4FDD79Q56619661-88DCBF1F-EF7E-4290-AB79-89DF5D10D4C5Q59166756-3235150B-022B-452E-8E42-EDAFF964AFC6
P2860
177Lu-labeled cyclic polyaminophosphonates as potential agents for bone pain palliation.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
177Lu-labeled cyclic polyaminophosphonates as potential agents for bone pain palliation.
@en
177Lu-labeled cyclic polyaminophosphonates as potential agents for bone pain palliation.
@nl
type
label
177Lu-labeled cyclic polyaminophosphonates as potential agents for bone pain palliation.
@en
177Lu-labeled cyclic polyaminophosphonates as potential agents for bone pain palliation.
@nl
prefLabel
177Lu-labeled cyclic polyaminophosphonates as potential agents for bone pain palliation.
@en
177Lu-labeled cyclic polyaminophosphonates as potential agents for bone pain palliation.
@nl
P2093
P1476
177Lu-labeled cyclic polyaminophosphonates as potential agents for bone pain palliation
@en
P2093
Grace Samuel
M R A Pillai
Meera Venkatesh
Sharmila Banerjee
Sudipta Chakraborty
P304
P356
10.1016/S0969-8043(02)00104-5
P577
2002-08-01T00:00:00Z